The answer may lie in how pharmaceutical companies are targeting their R&D spending.
Researchers: Efraim Benmelech, Janice C. Eberly, Joshua Krieger and Dimitris Papanikolaou
June 1, 2021
A new study suggests that firms are at their most innovative after a financial windfall.
Researchers: Joshua Krieger, Danielle Li and Dimitris Papanikolaou
September 6, 2018